Article Versions Notes

Lin D, Reddy V, Osman H, Lopez A, Koksal AR, Rhadhi SM, Dash S, Aydin Y. Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients. Cells. 2021; 10(4):790. https://doi.org/10.3390/cells10040790

Lin, Dong, Venu Reddy, Hanadi Osman, Adriana Lopez, Ali Riza Koksal, Sadeq Mutlab Rhadhi, Srikanta Dash, and Yucel Aydin. 2021. "Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients" Cells 10, no. 4: 790. https://doi.org/10.3390/cells10040790

Lin, D., Reddy, V., Osman, H., Lopez, A., Koksal, A. R., Rhadhi, S. M., Dash, S., & Aydin, Y. (2021). Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients. Cells, 10(4), 790. https://doi.org/10.3390/cells10040790